Screening for Pancreatic Cancer
- 6 August 2019
- journal article
- review article
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 322 (5), 438-444
- https://doi.org/10.1001/jama.2019.10232
Abstract
ImportancePancreatic cancer is an uncommon cancer with an age-adjusted annual incidence of 12.9 cases per 100000 person-years. However, the death rate is 11.0 deaths per 100000 person-years because the prognosis of pancreatic cancer is poor. Although its incidence is low, pancreatic cancer is the third most common cause of cancer death in the United States. Because of the increasing incidence of pancreatic cancer, along with improvements in early detection and treatment of other types of cancer, it is estimated that pancreatic cancer may soon become the second-leading cause of cancer death in the United States. ObjectiveTo update the 2004 US Preventive Services Task Force (USPSTF) recommendation on screening for pancreatic cancer. Evidence ReviewThe USPSTF reviewed the evidence on the benefits and harms of screening for pancreatic cancer, the diagnostic accuracy of screening tests for pancreatic cancer, and the benefits and harms of treatment of screen-detected or asymptomatic pancreatic cancer. FindingsThe USPSTF found no evidence that screening for pancreatic cancer or treatment of screen-detected pancreatic cancer improves disease-specific morbidity or mortality, or all-cause mortality. The USPSTF found adequate evidence that the magnitude of the benefits of screening for pancreatic cancer in asymptomatic adults can be bounded as no greater than small. The USPSTF found adequate evidence that the magnitude of the harms of screening for pancreatic cancer and treatment of screen-detected pancreatic cancer can be bounded as at least moderate. The USPSTF reaffirms its previous conclusion that the potential benefits of screening for pancreatic cancer in asymptomatic adults do not outweigh the potential harms. Conclusions and RecommendationThe USPSTF recommends against screening for pancreatic cancer in asymptomatic adults. (D recommendation)This publication has 37 references indexed in Scilit:
- Incidentally Discovered Pancreatic Intraepithelial Neoplasia: What Is Its Clinical Significance?Annals of Surgical Oncology, 2013
- Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk IndividualsGastroenterology, 2012
- Genetic susceptibility to pancreatic cancerMolecular Carcinogenesis, 2011
- Postoperative Complications Deteriorate Long-Term Outcome in Pancreatic Cancer PatientsAnnals of Surgical Oncology, 2011
- Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer FamiliesThe American Journal of Gastroenterology, 2011
- German national case collection for familial pancreatic cancer (FaPaCa): ten years experienceFamilial Cancer, 2011
- Pancreatic Cancer Screening in a Prospective Cohort of High-Risk Patients: A Comprehensive Strategy of Imaging and GeneticsClinical Cancer Research, 2010
- Perioperative Mortality for PancreatectomyAnnals of Surgery, 2007
- Screening for Early Pancreatic Neoplasia in High-Risk Individuals: A Prospective Controlled StudyClinical Gastroenterology and Hepatology, 2006
- Clinicopathological Correlates of Pancreatic Intraepithelial Neoplasia: A Comparative Analysis of 82 Cases With and 152 Cases Without Pancreatic Ductal AdenocarcinomaLaboratory Investigation, 2003